Company Filing History:
1 out of 7 
1 out of 29 Years Active: 2011
Title: Masayuki Kurooka: Innovator in Antitumor Pharmaceutical Composition
Introduction
Masayuki Kurooka is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that have antitumor effects. His innovative approach utilizes viral envelope vectors to enhance the delivery of chemotherapeutic agents.
Latest Patents
Kurooka holds 1 patent for his invention titled "Composition having antitumor effect." This patent focuses on a pharmaceutical composition designed to deliver chemotherapeutic drugs into cells or living organisms using a viral envelope vector. The composition aims to encapsulate an anticancer drug within a viral envelope vector, which can be coadministered with another anticancer drug to induce tumor cell-specific antitumor immunity. This innovative method allows for direct introduction of the drug into tumors, potentially leading to tumor regression.
Career Highlights
Throughout his career, Kurooka has worked with various companies, including Genomidea Inc. and Anges MG, Inc. His work in these organizations has contributed to advancements in pharmaceutical technologies and cancer treatment methodologies.
Collaborations
Kurooka has collaborated with notable professionals in his field, including Hitoshi Kotani and Yasufumi Kaneda. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in cancer therapy.
Conclusion
Masayuki Kurooka's contributions to the pharmaceutical industry, particularly in antitumor compositions, highlight his role as an influential inventor. His innovative use of viral envelope vectors in drug delivery represents a significant advancement in cancer treatment.